Missed diagnostic testing has negative impact on lung cancer treatment

the ONA take:

A team of researchers from the Baptist Cancer Center and the University of Memphis, Tennessee, sought to identify the impact of factors associated with care delivery on prognosis for patients with lung cancer.

Their results show that only 1 in 10 patients with lung cancer underwent the recommended combination of diagnostic tests before surgery. In addition, patients waited 1.5 to 6 months to undergo surgery after suspicions of lung cancer are made via radiography.

Recommendations suggest three staging tests before surgery in patients for suspected lung cancer: computed tomography (CT), positron emission tomography (PET), and a biopsy.

According to the study results, 88% of patients did not undergo biopsy, no imaging test was obtained in 22% of patients, and no diagnostic procedure was done before surgery in 27% of patients.

The researchers conclude that delays in final treatment and missed diagnostic tests can hinder outcomes for patients with lung cancer.

Their results highlight the importance of engaging patients in their care from early on to determine the best tests that will lead to an optimal treatment course for that patient.

Missed diagnostic testing has a negative impact on lung cancer treatment
A team sought to identify the impact of factors associated with care delivery on prognosis for patients with lung cancer.
New research published in The Annals of Thoracic Surgery finds that many patients with suspected lung cancer miss diagnostic testing, leading to delays in treatment for the condition. After the initial identification of suspected lung cancer via X-ray, the researchers found it took an average of 1.5-6 months for the majority of patients to receive surgery.
READ FULL ARTICLE From Medical News Today
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs